| | Study ID | Gender male/female | Base-line information | Average age (years) | Interventions | Control | Duration of treatment (days) | Outcome measures |
| |
Ji and Yin 2006 [10] | 59/35 | Age, sex, condition | 45.2 | Astragalus injection (250 mL i.d, qd) | 5% glucose injection | 30 | -MG, mAlb | |
Hua et al. 2009 [17] | 84/43 | Age, sex, blood pressure, duration | 44.3 | Astragalus injection (250 mL i.d, qd) calcium channel blockers (CCB), ACEI/ARB, thiazine diuretics | CCB,ACEI/ARB, thiazine diuretics | 20 | Twenty-four hours urinary protein content, blood pressure, urinalysis, renal function | |
Xu et al. 2008 [11] | 28/20 | Age, sex, blood pressure | | Astragalus injection (250 mL i.d, qd) Telmisartan, Plendil | Telmisartan, Plendil | 21 | Twenty-four hours urinary protein content, blood pressure, mAlb, serum potassium, pulse pressure, estimated glomerular filtration rate (eGFR) | | He 2004 [12] | 78/18 | Age, sex | 74.2 | Astragalus injection (500 mL i.d, qd) | Prostaglandin (PGE1) | 15 | BUN, Scr, Ccr | |
Yao et al. 2002 [13] | 38/26 | Age, sex, blood pressure | | Astragalus injection (250 mL i.d, qd) Lotensin, Plendil | Lotensin, Plendil | 21 | Twenty-four hours urinary protein content |
|
|
